Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis

R G Borroni, A Costanzo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)266
JournalBr. J. Dermatol.
Volume182
Issue number2
DOIs
Publication statusPublished - Feb 2020

Keywords

  • Adalimumab
  • Biosimilar Pharmaceuticals
  • Double-Blind Method
  • Humans
  • Psoriasis
  • Severity of Illness Index

Cite this